One silver lining of the COVID-19 pandemic is that it has accelerated the rate of change for pharma and life sciences fields in general.
The pandemic has forced a rethink of how to manage clinical trials and treat patients in hospitals and their homes. And the breakneck speed of vaccine development in 2020 could potentially lead to accelerated timelines for other therapeutics in the future.
The coming year of 2021 will likely be another pivotal year for the life sciences field at large, and drug developers in particular. Here, we asked several experts to predict the trends that will be most relevant in the coming year.
Get the full story from our sister site Drug Discovery & Development.